iSpecimen Inc.ISPCEarnings & Financial Report
Specimen Products is a Chicago-based manufacturer of custom guitars, tube amplifiers, and audio horn speakers led by luthier Ian Schneller. Specimen Products also offers courses in guitar and tube amplifier design, construction, and repair through their Chicago School of Guitar Making. The Specimen workshop offers repair services to the general public, making use of their collection of parts from rare and vintage manufacturers.
Revenue
$2.9M
Gross Profit
$1.5M
Operating Profit
$-2.2M
Net Profit
$-2.1M
Gross Margin
51.9%
Operating Margin
-76.2%
Net Margin
-73.6%
YoY Growth
76.2%
EPS
$-3.72
iSpecimen Inc. Q2 FY2024 Financial Summary
iSpecimen Inc. reported revenue of $2.9M (up 76.2% YoY) for Q2 FY2024, with a net profit of $-2.1M (up 39.5% YoY) (-73.6% margin). Cost of goods sold was $1.4M, operating expenses totaled $3.7M.
Key Financial Metrics
| Total Revenue | $2.9M |
|---|---|
| Net Profit | $-2.1M |
| Gross Margin | 51.9% |
| Operating Margin | -76.2% |
| Report Period | Q2 FY2024 |
iSpecimen Inc. Annual Revenue by Year
iSpecimen Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $9.3M).
| Year | Annual Revenue |
|---|---|
| 2024 | $9.3M |
| 2023 | $9.9M |
| 2022 | $10.4M |
iSpecimen Inc. Quarterly Revenue & Net Profit History
iSpecimen Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q2 FY2025 | $713.1K | -75.1% | $-1.0M | -146.9% |
| Q1 FY2025 | $1.1M | -53.8% | $-1.7M | -156.8% |
| Q4 FY2024 | $1.5M | -42.7% | $-6.0M | -409.8% |
| Q3 FY2024 | $2.7M | -4.2% | $-1.4M | -54.1% |
| Q2 FY2024 | $2.9M | +76.2% | $-2.1M | -73.6% |
| Q1 FY2024 | $2.3M | -22.4% | $-2.9M | -126.7% |
| Q4 FY2023 | $2.6M | -13.0% | $-3.1M | -119.3% |
| Q3 FY2023 | $2.8M | +7.5% | $-2.1M | -76.0% |
Income Statement
| Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.8M | $2.6M | $2.3M | $2.9M | $2.7M | $1.5M | $1.1M | $713135 |
| YoY Growth | 7.5% | -13.0% | -22.4% | 76.2% | -4.2% | -42.7% | -53.8% | -75.1% |
Balance Sheet
| Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $16.3M | $15.8M | $12.5M | $11.9M | $11.3M | $9.4M | $6.8M | $6.0M |
| Liabilities | $3.6M | $6.1M | $5.7M | $5.8M | $6.5M | $6.0M | $5.2M | $5.4M |
| Equity | $12.7M | $9.7M | $6.8M | $6.1M | $4.7M | $3.3M | $1.7M | $621973 |
Cash Flow
| Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-1.6M | $345141 | $-2.1M | $-1.5M | $-1.1M | $-3.6M | $-1.1M | $-192234 |